Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01-12-2019 | Incontinentia Pigmenti | Research

Incontinentia pigmenti burden scale: designing a family burden questionnaire

Authors: Charles Taieb, Smail Hadj-Rabia, Jacques Monnet, Mohammed Bennani, Christine Bodemer, the Filière Maladies Rares en Dermatologie

Published in: Orphanet Journal of Rare Diseases | Issue 1/2019

Login to get access

Abstract

Background

Incontentia pigmenti (IP) is a rare multisystem disorder of ectodermal origin comprising skin, dental, ocular and central nervous system features. Symptomatic treatments are adapted to each family according to the patient’s disability. Due to its rarity, the family IP burden in its broadest sense (psychological, social, economic and physical) has not yet been evaluated.

Aim

To design a questionnaire allowing assessing the family burden of IP (F’BoIP).

Method

A questionnaire was developed using a standardized methodology for designing quality of life questionnaires according to the following steps: conception, development, and validation. A multidisciplinary working group was designed, including experts in questionnaire development, dermatologists specialised in IP patient care and representatives of the French IP association. A cultural and linguistic validation into US English was conducted, based on the original French version.

Results

A 20-item conceptual questionnaire was generated. Subsequent confirmatory analyses produced a 20-item questionnaire grouped into four domains, demonstrating internal consistency (Cronbach’s alpha: 0.93), reproducibility and high reliability. The F’BoIP questionnaire significantly correlated with other validated questionnaires: Family Dermatology Life Quality Index (F-DLQI), Perceived Stress Scale (PSS) and SF-12 mental and SF12 physical scores, indicating good external validity.

Conclusion

The F’BoIP questionnaire is the first specific tool to assess the family burden of IP and can be used by both family members of IP patients and by health care professionals. It is a valuable tool which evaluates medical and nonmedical strategies to improve the daily life of families affected by this orphan disease.
Literature
1.
go back to reference Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The international Incontinentia Pigmenti (IP) consortium. Nature. 2000;405:466–72.CrossRef Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The international Incontinentia Pigmenti (IP) consortium. Nature. 2000;405:466–72.CrossRef
2.
go back to reference Alshenqiti A, Nashabat M, AlGhoraibi H, et al. Pulmonary hypertension and vasculopathy in incontinentia pigmenti: a case report. Ther Clin Risk Manag. 2017;13:629–34.CrossRef Alshenqiti A, Nashabat M, AlGhoraibi H, et al. Pulmonary hypertension and vasculopathy in incontinentia pigmenti: a case report. Ther Clin Risk Manag. 2017;13:629–34.CrossRef
3.
go back to reference Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet. 1993;30:53–9.CrossRef Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet. 1993;30:53–9.CrossRef
4.
go back to reference Minic S, Trpinac D, Obradovic M. Incontinentia pigmenti diagnostic criteria update. Clin Genet. 2014;85:536–42.CrossRef Minic S, Trpinac D, Obradovic M. Incontinentia pigmenti diagnostic criteria update. Clin Genet. 2014;85:536–42.CrossRef
5.
go back to reference Meyer N, Paul C, Feneron D, et al. Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol. 2010;24:1075–82.PubMed Meyer N, Paul C, Feneron D, et al. Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol. 2010;24:1075–82.PubMed
6.
go back to reference Boccara O, Meni C, Leaute-Labreze C, et al. Haemangioma family burden: creation of a specific questionnaire. Acta Derm Venereol. 2015;95:78–82.CrossRef Boccara O, Meni C, Leaute-Labreze C, et al. Haemangioma family burden: creation of a specific questionnaire. Acta Derm Venereol. 2015;95:78–82.CrossRef
7.
go back to reference Dufresne H, Hadj-Rabia S, Méni C, et al. Family burden in inherited ichthyosis: creation of a specific questionnaire. Orphanet J Rare Dis. 2013;8:28.CrossRef Dufresne H, Hadj-Rabia S, Méni C, et al. Family burden in inherited ichthyosis: creation of a specific questionnaire. Orphanet J Rare Dis. 2013;8:28.CrossRef
8.
go back to reference Taieb A, Boralevi F, Seneschal J, et al. Atopic dermatitis burden scale for adults: development and validation of a new assessment tool. Acta Derm Venereol. 2015;95:700–5.CrossRef Taieb A, Boralevi F, Seneschal J, et al. Atopic dermatitis burden scale for adults: development and validation of a new assessment tool. Acta Derm Venereol. 2015;95:700–5.CrossRef
9.
go back to reference Salzes C, Abadie S, Seneschal J, et al. The Vitiligo impact patient scale (VIPs): development and validation of a Vitiligo burden assessment tool. J Invest Dermatol. 2016;136:52–8.CrossRef Salzes C, Abadie S, Seneschal J, et al. The Vitiligo impact patient scale (VIPs): development and validation of a Vitiligo burden assessment tool. J Invest Dermatol. 2016;136:52–8.CrossRef
10.
go back to reference Morice-Picard F, Taieb C, Marti A, et al. Burden of albinism: development and validation of a burden assessment tool. Orphanet J Rare Dis. 2018;13:162.CrossRef Morice-Picard F, Taieb C, Marti A, et al. Burden of albinism: development and validation of a burden assessment tool. Orphanet J Rare Dis. 2018;13:162.CrossRef
11.
go back to reference Hickman G, Bodemer C, Bourrat E, et al. Palmoplantar keratoderma: creating a disease burden questionnaire. J Eur Acad Dermatol Venereol. 2019;33:e291–3.PubMed Hickman G, Bodemer C, Bourrat E, et al. Palmoplantar keratoderma: creating a disease burden questionnaire. J Eur Acad Dermatol Venereol. 2019;33:e291–3.PubMed
12.
go back to reference Basra MK, Sue-Ho R, Finlay AY. The family dermatology life quality index: measuring the secondary impact of skin disease. Br J Dermatol. 2007;156:528–38.CrossRef Basra MK, Sue-Ho R, Finlay AY. The family dermatology life quality index: measuring the secondary impact of skin disease. Br J Dermatol. 2007;156:528–38.CrossRef
13.
go back to reference Rees J, O'Boyle C, MacDonagh R. Quality of life: impact of chronic illness on the partner. J R Soc Med. 2001;94:563–6.CrossRef Rees J, O'Boyle C, MacDonagh R. Quality of life: impact of chronic illness on the partner. J R Soc Med. 2001;94:563–6.CrossRef
14.
go back to reference Sampogna F, Finlay AY, Salek SS, et al. Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instruments. J Eur Acad Dermatol Venereol. 2017;31:1429–39.CrossRef Sampogna F, Finlay AY, Salek SS, et al. Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instruments. J Eur Acad Dermatol Venereol. 2017;31:1429–39.CrossRef
15.
go back to reference Seidenberg M, Haltiner A, Taylor MA, et al. Development and validation of a multiple ability self-report questionnaire. J Clin Exp Neuropsychol. 1994;16:93–104.CrossRef Seidenberg M, Haltiner A, Taylor MA, et al. Development and validation of a multiple ability self-report questionnaire. J Clin Exp Neuropsychol. 1994;16:93–104.CrossRef
16.
go back to reference Kaiser HF. The varimax criterion for analytic rotation in factor analysis. Pyschometrika. 1958;23:187–200.CrossRef Kaiser HF. The varimax criterion for analytic rotation in factor analysis. Pyschometrika. 1958;23:187–200.CrossRef
17.
go back to reference Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990;107:238–46.CrossRef Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990;107:238–46.CrossRef
18.
go back to reference Lim LL, Fisher JD. Use of the 12-item short-form (SF-12) health survey in an Australian heart and stroke population. Qual Life Res. 1999;8:1–8.CrossRef Lim LL, Fisher JD. Use of the 12-item short-form (SF-12) health survey in an Australian heart and stroke population. Qual Life Res. 1999;8:1–8.CrossRef
19.
go back to reference Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.CrossRef Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.CrossRef
20.
go back to reference Wild D, Grove A, Martin M, Eremenco S, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94–104.CrossRef Wild D, Grove A, Martin M, Eremenco S, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94–104.CrossRef
Metadata
Title
Incontinentia pigmenti burden scale: designing a family burden questionnaire
Authors
Charles Taieb
Smail Hadj-Rabia
Jacques Monnet
Mohammed Bennani
Christine Bodemer
the Filière Maladies Rares en Dermatologie
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2019
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-019-1234-y

Other articles of this Issue 1/2019

Orphanet Journal of Rare Diseases 1/2019 Go to the issue